Ocular Therapeutix
OCUL
$4.20
Share price
-9.58%
Change (1 day)
-28.81%
Change (1 year)
Categories
Market capitalization of Ocular Therapeutix (OCUL)
Market cap: $0.62 Billion
As of April 2024 Ocular Therapeutix has a market cap of $0.62 Billion. This makes Ocular Therapeutix the world's 5696th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Ocular Therapeutix from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.62 B | 21.88% |
| 2023 | $0.51 B | 136.68% |
| 2022 | $0.21 B | -59.47% |
| 2021 | $0.53 B | -66.06% |
| 2020 | $1.57 B | 691.24% |
| 2019 | $0.19 B | 20.32% |
| 2018 | $0.16 B | 26.14% |
| 2017 | $0.13 B | -37.09% |
| 2016 | $0.20 B | -10.2% |
| 2015 | $0.23 B | -53.78% |
| 2014 | $0.50 B |
End of Day market cap according to different sources
On Apr 25th, 2024 the market cap of Ocular Therapeutix was reported to be:
$0.62 Billion
$0.62 Billion
$0.62 Billion
$0.64 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | $0.37 B | -40.32% | 🇺🇸 USA |
 Anika Therapeutics ANIK | $0.37 B | -39.15% | 🇺🇸 USA |
 Intersect ENT XENT | $0.95 B | 52.97% | 🇺🇸 USA |
 Haemonetics HAE | $4.45 B | 613.18% | 🇺🇸 USA |